缩写名/全名 |
PULM PHARMACOL THER
PULMONARY PHARMACOLOGY & THERAPEUTICS |
||||||||||||||||||||||||
ISSN号 | 1094-5539 | ||||||||||||||||||||||||
研究方向 | 医学-呼吸系统 | ||||||||||||||||||||||||
影响因子 | 2015:2.93, 2016:2.525, 2017:2.406, 2018:2.669, 2019:2.681, | ||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||||||
年文章数 | 77 | ||||||||||||||||||||||||
出版年份 | 1997 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 来源Elsevier官网:平均9.7周 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | https://www.evise.com/evise/faces/pages/navigation/NavController.jspx? | ||||||||||||||||||||||||
投稿官网 | http://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics/#description | ||||||||||||||||||||||||
h-index | 66 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1094-5539%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway Author: Guangxia Yang, Lei Lyu, Xinhua Wang, Liang Bao, Beili Lyu, Zikai Lin Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, Vol., , DOI:10.1016/j.pupt.2019.03.011 DOI |
2. | GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation Author: Lei Jiang, Qing Jiang, Songlin Yang, Shicong Huang, Xiaoli Han, Jun Duan, Shangha Pan, Mingyan Zhao, Shuliang Guo Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, Vol.54, 77-86, DOI:10.1016/j.pupt.2018.12.004 DOI |
3. | Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway Author: Jinyan Ye, Minqiang Guan, Yao Lu, Dan Zhang, Chengye Li, Caicun Zhou Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, Vol.54, 53-59, DOI:10.1016/j.pupt.2018.12.001 DOI |
4. | Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis Author: Li-Bo Zhang, Min He Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, Vol.54, 39-52, DOI:10.1016/j.pupt.2018.11.007 DOI |
5. | Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo Author: Zhen Ma, Cungang Zhao, Qi Chen, Chenhuan Yu, Huanhuan Zhang, Zhimin Zhang, Wenhai Huang, Zhengrong Shen Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, Vol.53, 100-106, DOI:10.1016/j.pupt.2018.10.006 DOI |
6. | Effects of fasudil on pulmonary hypertension in clinical practice Author: Yiqing Zhang, Shangjie Wu Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, Vol.46, 54-63, DOI:10.1016/j.pupt.2017.08.002 DOI |
7. | Non-asthmatic eosinophilic bronchitis and its relationship with asthma Author: Kefang Lai, Ruchong Chen, Wen Peng, Wenzhi Zhan Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, Vol.47, 66-71, DOI:10.1016/j.pupt.2017.07.002 DOI |
8. | HMGB1 promotes HLF-1 proliferation and ECM production through activating HIF1-α-regulated aerobic glycolysis Author: JianNing Xu, JingYing Li, ZhiHong Yu, HaiWei Rao, Shu Wang, HaiBing Lan Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, Vol.45, 136-141, DOI:10.1016/j.pupt.2017.05.015 DOI |
9. | Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2/STATs and apoptosis in rat Author: Congcong Li, Liyan Bo, Pengcheng Li, Xi Lu, Wangping Li, Lei Pan, Yani Sun, Deguang Mu, Wei Liu, Faguang Jin Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, Vol.45, 69-79, DOI:10.1016/j.pupt.2017.05.002 DOI |
10. | Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways Author: Li Lin, Yan Yin, Gang Hou, Dan Han, Jian Kang, Qiuyue Wang Journal: PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, Vol.44, 111-121, DOI:10.1016/j.pupt.2017.03.014 DOI |
|
|